Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07207200

Impact of Morning Light Therapy in IBD

The Effects of Morning Light Therapy on IBD Activity and Symptoms

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The pilot study will focus on the effects of morning light therapy (MLT) in adult patients with ulcerative colitis (UC) who have evidence of poor sleep quality and active inflammation. The specific population is at risk for circadian rhythm sleep-wake disorders and has significant potential benefit from circadian realignment, which may lead to improved sleep quality and, ultimately, UC-related inflammatory activity. During an initial one-week lead-in period, participants will obtain baseline circadian-related labs, complete symptom-related surveys, and use a wearable device continuously to obtain baseline sleep-wake data. After the lead-in week, patients will undergo one hour of MLT while wearing wearable devices continuously and completing daily symptom surveys. At the end of four weeks of MLT, patients will obtain post-intervention circadian and inflammatory assessments in addition to completing the same symptom-related surveys.

Conditions

Interventions

TypeNameDescription
DEVICEMorning Light TherapyOne hour of morning light therapy each day for four weeks

Timeline

Start date
2026-03-01
Primary completion
2027-07-01
Completion
2027-07-01
First posted
2025-10-03
Last updated
2026-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07207200. Inclusion in this directory is not an endorsement.